Sold as Aclovate. Every FDA application for this active ingredient: 2 branded and 6 generic.
As of Nov 16, 2026, FDA lists 8 applications for Alclometasone Dipropionate (sold as Aclovate), first approved Dec 14, 1982, with 1 new use approved and 0 published complete response letters.
| Product | Part | Spending, 2025 | Change | Beneficiaries |
|---|---|---|---|---|
| Alclometasone Dipropionate | Part D | $677K | -63% | 9,352 |
| Dec 14, 1982 | AclovateNDA 18702 · New molecular entity | Fougera | 9 | Discontinued |
| Dec 14, 1982 | AclovateNDA 18707 · New dosage form | Fougera | 9 | Discontinued |
| Jul 29, 2004 | Alclometasone DipropionateANDA 76730 | Sun Pharma Canada | 1 | Marketed |
| Jul 12, 2005 | Alclometasone DipropionateANDA 76973 | Fougera Pharms | 1 | Marketed |
| Jul 18, 2005 | Alclometasone DipropionateANDA 76884 | Fougera Pharms | 1 | Marketed |
| Sep 15, 2005 | Alclometasone DipropionateANDA 76587 | Sun Pharma Canada | 1 | Marketed |
| Jun 23, 2009 | Alclometasone DipropionateANDA 79061 | Glenmark Pharms Ltd | 1 | Discontinued |
| Jul 30, 2009 | Alclometasone DipropionateANDA 79227 | Glenmark Pharms Ltd | 1 | Discontinued |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA